pain

For most people with multiple sclerosis (MS), the use of disease-modifying therapies, or DMTs, does not affect their perceived pain, according to a survey-based study in Australia. As few as one-third of MS patients who had ever used DMTs reported a change in pain, while one-eighth of those…

My hips have hurt for several years. Right now, it’s just a dull ache. But there have been times when it has been a shooting pain. Hip pain isn’t necessarily connected to your multiple sclerosis (MS), but it could be. It might be caused by alterations in your…

Noninvasive brain stimulation (NIBS) may be able to reduce fatigue, spasticity, and pain, and improve quality of life in patients with multiple sclerosis (MS), a new meta-analysis reports. The review assessed several NIBS interventions targeting different brain regions. The results suggest that these techniques can have immediate effects…

Cionic‘s leg-worn Neural Sleeve, recently authorized in the U.S. to aid walking in people with multiple sclerosis (MS) and other conditions that impair mobility, reduced foot drop in a small clinical trial. Patients in the trial also reported marked reductions in pain and mental health problems, according to…

Greater engagement in social activities and positive social support were associated with better physical and psychological health among people with multiple sclerosis (MS) in a recent study. These data “suggest that social integration and social support should be a crucial part of MS management,” the researchers wrote, adding that…

The addition of neurodynamic therapy — a type of manual therapy targeting the nerves — to a standard treatment regimen using several different approaches reduced pain sensitivity and improved dexterity in people with multiple sclerosis (MS), according to data from a clinical trial. “To the best of our…

Move along, move along. Nothing to read here. What a great start to a column! Last week, my worries about MS lifted as I was consumed by a glitch in my computer software. I’m pleased to report that I’ve found a whole series of admittedly fiddly workarounds. I’m even…

So, where was I last week? I was in the midst of writing this column when I was felled overnight by my long-term nemesis: a urinary tract infection (UTI). As usual, I had no idea I had one — but hey, I was ill. I’m sure I’ve banged on…

I have to admit, I’ve wheeled down the THC path a few times before. Yes, I know it’s very difficult to stay on the path when under the influence. Luckily, I’ve solved this problem by only imbibing in bed. I say imbibing, because for me, smoking the stuff is…

Lately, I’ve been thinking about pain — specifically, how to count my pain. When I was lying on a treatment table while my physical therapist Richard manipulated my shoulder, he asked me to rate my pain, on a scale from one to 10. I’m sure many of you…

A class of molecules called positive allosteric modulators, or PAMs, may be useful in treating pain caused by nerve damage — a common symptom of multiple sclerosis (MS) — according to a new study that sheds light on how these molecules work. The international team of researchers behind…

The light of the television screen illuminates the darkness. I want so much to sleep, but my body has other plans. After a hot shower and multiple medications, my legs continue to dance. The constant ache, twitch, and kick are a rhythmic routine. But my body is tired and…

People newly diagnosed with clinically isolated syndrome (CIS) or multiple sclerosis (MS) frequently experience pain, fatigue, depression, and anxiety in the first year after diagnosis, a new study finds. Fatigue was reported by almost two-thirds of new patients, and half experienced pain. Many individuals experienced multiple symptoms simultaneously,…

I have always liked the odd horror movie, the odder the better. I was a bit of a fan of the trash Troma Studio mob, where their tongue was so firmly in their cheek it usually stuck right through it. For you youngsters out there, think the “Sharknado”…

Many years ago I thrust myself into the Edinburgh International Festival. For the many who have never heard of it: It’s the largest arts festival in the world, encompassing theater, mime, dance, comedy, film, books, and sometimes even a splash of opera. For some reason I even sat through…

I was listening to a BBC podcast recently titled “The Sinister Hand,” about the history of left-handers. It seems that in medieval times, left-handedness was associated with sorcery. (What wasn’t?) It was only relatively recently that left-handed children were no longer forced to write right-handed — sometimes even…

Many believe pain and suffering are interchangeable. While they can and often do coexist, one is not reliant on the other. Pain can occur with or without suffering, and the inverse is true. Physiological, psychological, and psychosocial factors influence our experience with each. The meanings and relationships of these three…

If I were using a wheelchair, would you question why I use a handicapped placard? Perhaps some (or all) of the condemnation I now receive would diminish. Maybe the notes left on my windshield would not be written. Perchance, it might temper some of the ugly comments spoken to my…

Overachieving is my jam. Go big or go home. I strive to be the best at whatever it is I do. Currently, I am achieving greatness in my ability to fall. Three falls in three weeks is a new record. The first one happened in the kitchen. Upon feeling myself…

Did you know that there are various types of fatigue, and each makes us feel slightly different than the others? A long while ago, I was at an MS seminar listening to a nurse talk about fatigue. She…

Eli Lilly has reached an agreement to acquire Disarm Therapeutics, a biotechnology company developing a new class of disease-modifying treatments for patients with axonal degeneration, including those with multiple sclerosis (MS). In its announcement, Lilly committed to advancing Disarm’s prospective therapies, currently in preclinical development.

When I was first diagnosed with MS, I didn’t have a choice about what disease-modifying therapy (DMT) I could take. My neurologist held up his hand and pointed one by one to each finger, with each…

It was 3 p.m. last Thursday. Things should have been good. I had filed the copy for my previous column the day before. Ultimately, some of my outrageous musings had gone, and some I considered even worse had stayed. It’s an age-old journalism, radio, and TV writer’s trick: If…

In a nationwide survey of cannabis-based therapy use among Americans with multiple sclerosis (MS), almost half of respondents endorsed such products, primarily for nerve-based pain and sleep disturbances, and the perceived benefits for sleep and pain were highly correlated.  The reported…

Symptoms including sleep disorders and pain may precede by as many as five years the onset of the more well-known symptoms of multiple sclerosis (MS), a study suggests. Understanding these first symptoms could aid in an early diagnosis, allowing treatment to begin at initial stages of disease. The…

Sativex (nabiximols) eases spasticity-associated symptoms in multiple sclerosis (MS) patients, including those with no significant improvements in a validated spasticity scale, according to a large study from Italy. The findings support previous studies suggesting that spasticity scales may not be enough to evaluate patients’ responses to Sativex and to…

Pain appears to be more intense in people with neuromyelitis optica spectrum disorder (NMOSD) than those with multiple sclerosis (MS), while fatigue levels are comparable between the two disorders, a study reports. Its researchers also link certain types of central nervous system lesions to pain and fatigue in…

About 85% of people with multiple sclerosis (MS) using cannabis find it to be helpful for pain, and 79% find it eases spasticity, a new study reports. The study, “Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis,” was published in…

Sativex (nabiximols), a THC:CBD oral spray, consistently relieves the pain and severity of treatment-resistant spasticity in multiple sclerosis (MS) patients, according to a recent study. An analysis of the Sativex as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) study revealed that Sativex, used in…

The United States Patent and Trademark Office (USPTO) has issued a patent to Endonovo Therapeutics for Application No. 15/549,748, which covers the company’s technique and device for electromagnetic treatment of multiple sclerosis (MS). Endonovo has a pipeline of “Electroceuticals” — wearable, electronic, non-invasive therapeutic devices. These devices…